Q2 FY27 earnings call · October 30, 2026

Welspun Living Q2 FY27 Earnings Call: Revenue Up 16.9% Despite Vapi Floods, Net Cash Milestone Achieved (WELSPUNLIV)

Cofacto ResearchPublished October 30, 20268 min read
Listen to the earnings call
Quick summary

Welspun Living Ltd held its Q2 FY27 earnings call on October 30, 2026. Here's a quick read of what management said — performance, strategy, and the outlook ahead.

Double-Digit Growth Despite Vapi Disruption; Net Cash Milestone

  • Revenue Rs.2,870 Cr, +16.9% YoY — consolidated Q2 FY 2026-2027 growth with double-digit expansion in both segments, despite flood disruption at the Vapi facility, where operations were restricted for several weeks.
  • EBITDA margin 12.9% — up 600 bps YoY and 40 bps QoQ, driven by operating efficiencies, procurement discipline, product mix and cost management; input costs and consumer demand remain dynamic.
  • Vapi floods cost Rs.100-150 Cr of Q2 top line — dispatches to UK and Europe were restricted; management indicated growth would otherwise have continued. Towel volumes (units and tonnage) are expected to normalize in Q3 FY 2026-2027.
  • Net cash position achieved — a swing from net debt of Rs.775 Cr at end of March 2026 (FY 2025-2026 close); cash conversion cycle improved from 82 days (March 2026) to 44 days in Q2 FY 2026-2027, with ROCE at 12.7%, hitting the FY27 low-teens goal ahead of schedule.
  • Home textiles exports +18.3% YoY — supported by healthy retailer demand ahead of the holiday season; domestic business grew 28.2% YoY on strong B2C across general trade, e-commerce and quick commerce.
  • Commodity headwinds persist — firm cotton prices (~68,000 as of the Q2 FY 2026-2027 call), rising man-made fiber and oil-linked input costs, and elevated freight amid Middle East tensions; being managed via procurement discipline, customer pricing discussions and productivity.

US Resilient, Europe FTA-Led, UK Share Capture

  • US: 60-70% of US business is replenishment programs (FY 2026-2027); management sees no impact from inflation risk flagged on the call, with consumption "steady state" and US growth guided at mid-to-high single digit (period unspecified).
  • Europe/UK growing ~20% (FY 2026-2027) — management is "cautiously optimistic" and expects to maintain that pace over the next two years (through FY 2028-2029), aided by the FTA; Q2 saw a "little blip" in Europe/UK because Vapi services those orders.
  • UK home textile market sized at $5-7 bn — management noted Pakistan currently holds ~55% of that market (primarily bed sheets); Welspun sees an opportunity to capture share, starting with bath towels and extending to bedding, sheets and rugs.
  • NGFTA (effective 20 Oct 2026, FY 2026-2027) — no opportunity size quantified; Dipali Goenka said retailer conversations "continue to fructify" and Welspun Living is "geared up for a 20% growth in this region" (period unspecified).
  • US tariffs: India currently at 10% — management said talks are ongoing and India will be at par with Pakistan, Bangladesh, China and Vietnam under the eventual trade agreement; 100% of the earlier tariff challenge has been mitigated, with BTA conversations ongoing.
  • FTA pipeline — management expects at least 53 FTAs to open with zero tariff for textiles in the near future (period unspecified); UK FTA has delivered early wins with customer factory visits and product development underway.
  • OTEXA data reading — per management, Welspun's US towel share increased in CY 2026 YTD even as India's share dropped; management acknowledged India's decline against the analyst's cited -17% YTD (CY 2026) figure and offered a follow-up to reconcile data.

Flooring Recovery, Pillows Scaling, Advanced Textiles an FY27 Aberration

  • Flooring revenue +19.3% YoY, EBITDA margin 10.8% in Q2 FY 2026-2027, improving sequentially and YoY on portfolio right-sizing and customer-mix discipline; management targets steady-state low double-digit margins (period unspecified), flagging PSF and polymer costs as swing factors. H1 FY 2026-2027 flooring revenue was ~Rs.400 Cr (analyst-cited); management targets Rs.800-1,000 Cr (period unspecified) and explicitly stated "nothing beyond that" — the analyst's Rs.1,500 Cr FY 2027-2028 path was not endorsed.
  • US pillow business grew 2.4x YoY in Q2 FY 2026-2027 with Ohio (83% utilized) and Nevada (52%) operational; volumes are doubling in FY 2026-2027 — H1 FY 2026-2027 has already doubled the FY 2025-2026 number. Business is currently around break-even.
  • Pillow revenue potential of $80-100 million at lower-teens margin at full capacity across both US plants; management expects the 80-100 million potential to be achieved by FY29.
  • Advanced textiles flat YoY in H1 FY 2026-2027 — hit by the commodity surge in a challenging man-made fiber scenario; management termed FY 2026-2027 an aberration, expects recovery in FY 2027-2028, and holds a board-level 20% EBITDA target for the segment with growth that "could reasonably be" double-digit over the next couple of years.
  • B2B innovation and domestic B2B each grew upward of 40% in Q2 FY 2026-2027, together roughly one-third of revenue (analyst-cited); CFO flagged "a couple of one-time" promotional orders but said the momentum is part of the sales-mix plan. 70-80% of total business is program-led (current mix, Q2 FY 2026-2027).
  • Home textiles ex-advanced textiles grew ~22% YoY in H1 FY 2026-2027 — management clarified growth is a mix of value and volume, with bed linen volume up 2% in H1 FY 2026-2027; analyst Soham Samata (Motilal Oswal) flagged bed volumes down 4% and bath up only 5%.

Gross Margin Rebound After Q1 Compression; Cotton Strategy Patient

  • Gross margin compressed ~250 bps in Q1 FY 2026-2027 on raw material price pressure; the Q2 FY 2026-2027 improvement reflected customer program mix, sales price and raw material, with the company's 6-9 months of inventory (per CFO Manish Bansal) supporting average realized price.
  • Margins "will actually improve" — CFO response to the analyst's ~45% steady-state gross margin framing for Q3-Q4 FY 2026-2027, dependent on customer mix; MD & CEO added management is "looking at a good steady state EBITDA margin" (unquantified).
  • Cotton at ~68,000 with 4-5 months cover beyond December 2026 — the company will take its own time before fresh buying decisions in the new season; any cotton-driven price increases will be implemented in collaboration with customers.
  • Other expenses declined QoQ in Q2 FY 2026-2027 — CFO attributed this to ongoing cost-optimization and productivity initiatives rather than a one-off; container costs are being managed via long-term contracts, and more than 90% of business is on FOB terms.
  • Cash conversion cycle at 44 days, expected to normalize to 55-60 days (period unspecified) — CFO called H1 FY 2026-2027 cash generation funded largely by incremental trade payables "business as usual."
  • Tariff refunds received but not in P&L as of Q2 FY 2026-2027 — amounts are under reconciliation with customers and customs and will probably start reflecting in financials sometime in Q3 FY 2026-2027.

FY28 Rs.15,000 Cr Intact; Multi-Year Framework Reaffirmed

  • FY28 top line guidance of close to Rs.15,000 crore reaffirmed — management said "the number is intact," with Dipali Goenka adding Welspun will maintain complete leadership in towels globally and is exploring additional investment opportunities.
  • Multi-year framework reaffirmed — responding to whether 14-15% top-line growth, 14-15% EBITDA margin and 15% ROC are conservatively achievable over the next 3-4 years (through FY 2029-2030/FY 2030-2031), Dipali Goenka reaffirmed the guidance the company has "promised": double-digit revenue growth and 15% EBITDA over the next 2 years (FY 2027-2028 to FY 2028-2029), adding "we will see around 14-15%" (period unspecified).
  • FY 2026-2027 guidance tracking — management said it is tracking the same top-line and EBITDA margin guidance given at the beginning of FY 2026-2027, in response to whether the 15-17% realization growth seen in H1 FY 2026-2027 will sustain in H2 FY 2026-2027.
  • FY 2026-2027 capex of Rs.400-500 Cr — ~Rs.150 Cr deployed in H1 FY 2026-2027; the balance ~Rs.350 Cr in H2 FY 2026-2027 goes to debottlenecking and capacity increase. Steady-state capex allocation remains roughly Rs.400-500 Cr per annum (period unspecified); FY 2027-2028 capex plans were deferred ("we'll come back to you on that").
  • AI and automation "going to be the way forward" for manufacturing economics per Dipali Goenka — adoption of Welvision AI is still evolving (agentic AI, vision AI for quality) and will be needed "across all our operations"; no productivity-gain figure was shared — management committed to revert later.

Vapi Restoration, Commodity Costs, Dynamic External Environment

  • Vapi restoration is the near-term execution priority — the plant has resumed partial operations and is working towards full capacity; spinning was impacted more than weaving, with production outsourced and Anjar providing support. Bath linen ran at 83% utilization in Q2 FY 2026-2027 despite limited Vapi contribution; management expects utilization around 90% going forward (period unspecified).
  • External environment remains dynamic — management believes the underlying strength of the business and actions taken position it well for the next phase of growth (no timeline specified).
  • Industry context (not a company commitment) — management cited India's increasing competitiveness in global sourcing, evolving trade relationships, and the growing importance of reliable supply chains as providing meaningful opportunities for the industry; global retailers are prioritizing dependable supply chains and sourcing diversification.
  • Sustainability progress — Anjar is now powered by 100% green electricity, and the Step Zero program is advancing the transition towards more sustainable supply chains.
  • Q3 FY 2026-2027 described as "quite promising" — with the holiday season underway and opportunities building in UK, Europe, rest of the world, India and the US; on the "BT" matter, management said it will continue and "we'll see how it pans out," on a level playing field.

Ask about this

Ask Cofacto a question about this call. Answers cite filings and company data.

Companies on this page

Related

Share on X · LinkedIn · WhatsApp

Disclaimer: This earnings call summary is published for educational and informational purposes only. It is not investment advice, not a recommendation to buy, sell or hold any security.